Conor Simpson

Commercialisation Executive, Faculty of Medicine

Conor is a Commercialisation Executive within Imperial Enterprise, supporting innovations arising from the Faculty of Medicine.

He works with Imperial academics to assess, protect and commercialise new technologies, focusing on opportunities in medical devices, diagnostics, AI for healthcare and pharmaceuticals.

Before joining Imperial, Conor was a Business Developer at Leiden University Medical Centre’s Technology Transfer Office, where he managed medical technology portfolios and negotiated licensing and spinout agreements. He also gained start-up experience at Idris Oncology, a medical device company developing in vivo diagnostic technologies. Conor holds an MSc in Bio-Pharmaceutical Sciences and Business Studies from Leiden University and a BSc (Hons) in Pharmacology from the University of Glasgow.

Conor's portfolio

PROPHSY: Proteome in Pulmonary Hypertension Assay Score

PROPHSY: Proteome in Pulmonary Hypertension Assay Score

A model score calculated from levels of circulating plasma proteins for the diagnosis, prognosis, and treatment optimisation of Pulmonary Arterial Hypertension. Find out more

A real-time fluorescence probe for Heme Oxygenase activity

A real-time fluorescence probe for Heme Oxygenase activity

Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders. Find out more

Functionalised biopolymer materials for extracellular vesicle isolation and engineering

Functionalised biopolymer materials for extracellular vesicle isolation and engineering

Methods for use in extracellular vesicle (EV), including exosomes, isolation and engineering applications broadly encompassing EV manufacturing, therapeutic, medical and diagnostics uses. Find out more

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines. Find out more

Portfolio of human colorectal adenocarcinomas

Portfolio of human colorectal adenocarcinomas

A portfolio of human colorectal adenocarcenoma cell lines including primary cell lines isolated from patients (of various Duke's stages and histological grades) in addition to cloned cells lines genetically modified to highly express alpha integrin domains. Find out more

Charcot-Marie Tooth Disease model

Charcot-Marie Tooth Disease model

Proposed use Research into Charcot-Marie Tooth Disease (Type 1A). Research into autoimmune neurological disorders would be the main ... Find out more

Complement Factor H Knock Out Mouse Model

Complement Factor H Knock Out Mouse Model

In the field of eye disease, such as age-related macular degeneration (AMD) this mouse model has been proven important for research into the mechanisms of disease. This disease model is useful for conditions in which complement factor H plays a role. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...